12ᵗʰ International Symposium on Hodgkin Lymphoma
back to
back to
  • Program
    • Schedule
    • 22.10.2022
    • 23.10.2022
    • 24.10.2022
    • Scientific Committee
  • Media
    • Photos
    • Videos
    • Downloads
    • Abstracts
  • Newsletters
  • Acknowledgements
  • Sponsors
  • Other Archives
    • ISHL12
    • Update on Hodgkin Lymphoma
    • ISHL11
    • ISHL10
    • ISHL9
    • ISHL8
    • ISHL7
Back to video list

Vision Corner Stimulus Talk: The future of translational science in HL

Speaker

Christian Steidl

Session

Immunotherapy

Others Talks of this Session

  • Vision Corner Stimulus Talk: Best use of PD1 blockade in frontline treatment
  • Vision Corner Stimulus Talk: Leveraging PD1 blockade for cure
  • Vision Corner: Discussion
  • New findings and new challenges since last ISHL
  • Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume
  • Safety and Dose-Expansion Study of Combination Favezelimab (anti–LAG-3) Plus Pembrolizumab in Anti–PD-1–Naive Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Quicklink

  1. Program
  2. General
  3. Sponsors
  4. Contact
  5. Partners
  1. Abstracts
  2. Downloads
  3. Legal Info
  4. Archive
  5. Privacy Policy

How to contact us

German Hodgkin Study Group (GHSG)
University Hospital of Cologne

Kerpener Str. 62
D-50924 Köln

info@hodgkinsymposium.org

This website uses cookies to ensure you get the best experience on our website. By using our site you agree to our use of cookies. Learn more